PPARG and chronic kidney disease: As presented in Figure 4, IF showed that the decreased expression of PPAR‐γ in CKD rats (vs control) was increased in the CKD + Rb1 group, while compared with that in the CKD group, β‐catenin expression was decreased in CKD + Rb1 rats (Figure 4A,B).